2016-06-14-世界卫生组织-PDVAC_List_of_Participants_2016_4页_182kb

Summary of WHO Product Development for Vaccines Advisory Committee Meeting

• Meeting: Took place from June 8 to 10, 2016, at WHO Headquarters in Geneva, Switzerland.
• Purpose: To advise on vaccine development, focusing on global health challenges, with sessions likely covering issues like vaccine innovation, regulatory pathways, and collaboration.
• Participants:
  • Committee members (10 individuals): Experts in vaccine research, science, and public health from various countries, including leadership from PATH, WHO institutes, and international health organizations.
  • Non-committee members (over 50 individuals): A wide range of experts, contractors, and representatives from organizations like the Gates Foundation, CDC, military research programs, and embassies, providing external insights on clinical trials, policy, and infectious disease threats.
  • Industry observers (12 representatives): Senior figures from pharmaceutical companies such as Sanofi Pasteur, GSK, and Bharat Biotech, offering perspectives on development partnerships and regulatory affairs.
  • WHO Secretariat: Staff supporting the meeting, including those involved in immunization programs and innovation coordination.
• Key themes: The meeting emphasized collaborative approaches to vaccine development, with discussions probably addressing emerging diseases, access issues, and international standards for vaccine safety and efficacy.